Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: APP Mutations
APP-C99 (tg13592)

General Information

Posted 2 October 2004

Transgene:

Tg mice overexpress the signal plus 99-amino acid carboxyl-terminal sequence (SbC) of β-APP under the control of a cytomegalovirus enhancer/β-actin promoter.

Mutation: C99 of β-APP (5 copies)

Promoter: α cytomegalovirus enhancer/β-actin promoter

Mouse Strain: The transgene is injected into fertilized eggs produced by mating between F1 of C57BL/6 x DBA/2. C57BL/6J generations N6 to N8. More than 10 generations (>N10). The transgenic male mice are crossed to C57BL/6 female mice. The litter size is 10-12 on average.

Phenotype

Neuropathological Analysis:

Tg mice developed Aβ-immunoreactive deposits within the skeletal muscle fibers after 6 to 12 months of age. The muscle fibers with Aβ-immunoreactive deposits increased and became vacuolated with age.

Behavioral:

Mice exhibit hypoactivity and spatial learning deficit associated with higher cytochrome oxidase activity seen in thalamic nuclei.

Availability

Contact:
Dr. Ken-ichiro Fukuchi
Department of Comparative Medicine
Tg13592 Schools of Medicine and Dentistry, University of Alabama at Birmingham,
Kaul 640B, 720 20th Street South,
Birmingham, AL 35294-0019.
Phone: 205-975-8715
Fax: 205-975-5519
Email: fukuchi@uab.edu

Patents: N/A

References

Primary:

Fukuchi K, Ho L, Younkin SG, Kunkel DD, Ogburn CE, Wegiel J, Wisniewski HM, LeBoeuf RC, Furlong CE, Deeb SS, Nochlin D, Sumi SM, Martin GM: High levels of β-amyloid protein in peripheral blood do not cause cerebral β-amyloidosis in transgenic mice. Am J Pathol 149:219-227, 1996. Abstract

Associated:

Fukuchi K., Pham D., Hart M., Li L., Lindsey J.R. ß-Amyloid protein deposition in skeletal muscle of transgenic mice: Possible modes of inclusion body myopathy. Am. J. Pathol. 153, 1687 1693, 1998. Abstract

Fukuchi K, Li L, Hart M, Lindsey JR. Accumulation of amyloid-beta protein in exocrine glands of transgenic mice overexpressing a carboxyl terminal portion of amyloid protein precursor. Int J Exp Pathol. 81(4):231-9, 2000. Abstract

Lalonde R, Dumont M, Fukuchi K, Strazielle C. Transgenic mice expressing the human C99 terminal fragment of betaAPP: effects on spatial learning, exploration, anxiety, and motor coordination. Exp Gerontol., 37(12):1401-12, 2002. Abstract.

Strazielle C, Dumont M, Fukuchi K, Lalonde R. Transgenic mice expressing the human C99 terminal fragment of betaAPP: effects on cytochrome oxidase activity in skeletal muscle and brain. J Chem Neuroanat. 27(4): 237-46, 2004. Abstract.



Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad